期刊文献+

国产替罗非班对急性冠脉综合症患者急诊介入治疗安全性和有效性 被引量:4

下载PDF
导出
摘要 目的观察国产替罗非班对急性冠脉综合症(ACS)急诊介入治疗安全性和有效性。方法本文入选住院ACS患者151例,随机分为对照组(75例)和替罗非班组(76例),比较两组基础临床资料、介入治疗情况、住院期间主要心脏不良事件(MACE)发生率和安全性(出血并发症)。结果两组患者基本临床资料和介入治疗情况差异均无统计学意义(P>0.05)。与对照组相比,替罗非班组可明显减少住院期间MACE的发生率(7.6%VS 20.0%)。虽然替罗非班组与对照组相比出血并发症无统计学意义上的差异,但是从临床观察看替罗非班确实有增加出血的倾向。结论国产替罗非班在国人ACS的急诊介入治疗过程中是有效的和安全的。
出处 《心脑血管病防治》 2009年第4期267-269,共3页 CARDIO-CEREBROVASCULAR DISEASE PREVENTION AND TREATMENT
  • 相关文献

参考文献10

  • 1Plate Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators. A comprision of aspirin plus tirofiban with aspirin plus heparin for unstable angina[J]. N Eng J Med, 1998,338:1498 - 1505.
  • 2Elmouchi DA, Bates ER. Platelet glycoprotein Ⅱb/Ⅲa inhibitor therapy in non-ST segment elevation acute coronary syndromes[J]. Minerva Cardloangiol,2003,51 (5) :547 - 560.
  • 3Heitzer, T Oflmann, I Koke, et al. Platelet Glycoprotein Ⅱb/Ⅲa Receptor Blockade Improves Vascular Nitric Oxide Bioavailability in Patients With Coronary ArteryDisease[J]. Circulation,2003,108 : 536 - 541.
  • 4Boers ma E, Harrington RA, Molitemo DJ, et al. Platelet glycop rotein Ⅱb/Ⅲa inhibitors in acute coronary syndr omes[J]. Lancet, 2002, 359: 189 - 198.
  • 5Lee DP, Herity NA, Hiatt BL, et al. Adjunctive platelet glycoprotein Ⅱ b/ Ⅲ a receptorinhibition with tirofibun before primary angioplasty improves angiographic outcomes: result-s of the tirofiban given in the emergency room before primary angioplasty(TIGER2PA) pilot trial[J]. Circulation, 2003, 107:1497- 1501.
  • 6Martinez-Rios MA, Rosas M, Gonalez H, et al. Comparison of reperfusion regimens with or without tirofiban in ST-elevation acute myocardial infarction[J]. Am J Cardiol,2004,93;280- 287.
  • 7The RESTORE investigators. Effects of platelet glycoprotein Ⅱ b/Ⅲ a blockade with tir-ofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty[J]. Circulation, 1997,96 : 1445 - 1453.
  • 8Brown DL. Deaths associated with platelet glycoprotein Ⅱ b/Ⅲ a inhibitor treatment[J]. Heart, 2003,89:535 - 553.
  • 9Sreedhara R, Itagaki I, Hakim R. Uremic Patients Have Decreased Shear2I nduced Platelet Aggregation Mediated by Decreased Availability of Clycopro- rein Ⅱb/Ⅲa Receptors[J]. Am j kidney dis, 1996,27:355-364.
  • 10De Queiroz Femandes Arau JO,Veloso HH, Braga De Paiva JM, et al. Efficacy and safety of abciximab on acute myocardial infarction treated with percutaneous coronary interventions: A meta-analysis of randomized, controlled trials[J]. Am Heart J, 2004,148:937-943.

同被引文献22

  • 1沈杰,沈卫峰.替罗非班在急性冠脉综合征介入治疗中的应用[J].国际心血管病杂志,2006,33(3):156-159. 被引量:72
  • 2沈杰,张奇,张瑞岩,张建盛,胡健,杨震坤,张宪,郑爱芳,沈卫峰.替罗非班在急性冠脉综合征患者中应用的安全性和出血相关因素分析[J].临床内科杂志,2007,24(1):14-17. 被引量:17
  • 3Yip HK, Chung SY, Chai HT, et al. Safety and efficacy of transra- dial vs transfemoral arterial primary coronary angioplasty for acute myocardial infarction : single-center experience [ J ]. Circ J, 2009, 73 ( 11 ) :2050 - 2055.
  • 4De Queiroz Femandes Arat~jo JO, Veloso HH, Braga De Paiva JM, et al. Efficacy and safety of abciximab on acute myocardial infarction treated with pereutaneous coronary interventions: A meta-analysis of randomized, controlled trials [ J ]. Am Heart J, 2004, 148 ( 6 ) :937 - 943.
  • 5Limbruno U, Micheli A, De Carlo M, et al. Mechanical prevention of distal embolization during primay angio-plasty : safety, feasibility, and impact on myocardial reperfusion [ J]. Circulation, 2003, 108 (2) :171 -176.
  • 6Valgimigli M, Campo G, Percoeo G. Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus- eluting or uncoated stents for acute myocardial infarction: the MUL- TISTRATEGY randomized trial[ J]. JAMA, 2008, 299 ( 15 ) : 1788 - 1799.
  • 7Brown DL. Deaths associated with platelet glyeoprotein IIb/IIIa in- hibitor treatment [ J ]. Heart, 2003, 89 (5) :535 - 537.
  • 8Sreedhara R, Itagaki I, Hakim RM. Uremic patients have decreased shear-induced platelet aggregation mediated by decreased availability of glycoprotein IIb-IIIa receptors[ J ]. Am J kidney dis, 1996, 27 (3) :355 -364.
  • 9Yip HK, Chung SY, Chai HT,et al . Safety and efficacy of transra-dial vs transfemoral arterial primary coronary angioplasty for acute myocardial infarction: single-center experience [J]. Circ J ,2009,73(11):2050-2055.
  • 10Valgimigli M,Campo G.Percoco G. Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MUL-TISTRATEGY randomizedtrial [ J ] ? JAMA ,2008,299(15):1788-1799.

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部